Sugammadex Linked to Lower Respiratory Risks After Endoscopy

Published Date: 29 Jun 2026

Block reversal using sugammadex is associated with better respiratory outcomes than that using neostigmine in adults undergoing upper gastrointestinal endoscopic procedures, a study finds.

Read Full News

Latest News

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

How Anesthesiologists Predict Who Will Throw Up After Surgery

— And how we prevent it

Dexamethasone, Ondansetron Show No Difference After Cesarean

Women who receive dexamethasone or ondansetron as antiemetics during cesarean delivery require a similar number of medications to manage postoperative side effects, a study shows.

Spanish Experts Expand Care After Perinatal Loss

Spanish neonatologists say memory boxes, cooling cradles, and follow-up care can help families navigate perinatal grief after the loss of a baby.

Acetaminophen and Autism: Data, Debate, and Risk

Experts examine methodological limitations, confounding factors, and inconsistent findings while considering how research quality shapes perceptions of potential harm.

Palliative Care Use in Hospitalized Hematologic Malignancies

In a national inpatient sample, palliative care reached just 10% of hematologic malignancy admissions, often only in the highest-acuity cases.

Todays Updates

Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD Samantha Pettigrew, MD

At CHEST 2026, Pettigrew reviewed STRATIFY and STORM-PE data, citing bleeding risk with low-dose alteplase and 90-day walk gains with thrombectomy.

AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD Jean Bourbeau, MD

At CHEST 2026, Jean Bourbeau, MD, said AI may support COPD diagnosis, remote monitoring, and posthospital care, though most tools still need validation.

Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD Henrik Watz, MD, PhD

Henrik Watz, MD, discusses 104-week OBERON, TITANIA, and PROSPERO data on tozorakimab in COPD presented at CHEST 2026.

Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD Gabor Kovacs, MD, PhD

Gabor Kovacs, MD, PhD, discusses phase 2a INSIGNIA PH-COPD results for inhaled frespaciguat presented at CHEST 2026.

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

Todays Updates

Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD Samantha Pettigrew, MD

At CHEST 2026, Pettigrew reviewed STRATIFY and STORM-PE data, citing bleeding risk with low-dose alteplase and 90-day walk gains with thrombectomy.

AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD Jean Bourbeau, MD

At CHEST 2026, Jean Bourbeau, MD, said AI may support COPD diagnosis, remote monitoring, and posthospital care, though most tools still need validation.

Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD Henrik Watz, MD, PhD

Henrik Watz, MD, discusses 104-week OBERON, TITANIA, and PROSPERO data on tozorakimab in COPD presented at CHEST 2026.

Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD Gabor Kovacs, MD, PhD

Gabor Kovacs, MD, PhD, discusses phase 2a INSIGNIA PH-COPD results for inhaled frespaciguat presented at CHEST 2026.

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

Latest News

Advances in Perioperative Pain Management: Integrating Emerging Non-Opioid Therapies Into Multimodal Treatment Pathways

— And how we prevent it

Women who receive dexamethasone or ondansetron as antiemetics during cesarean delivery require a similar number of medications to manage postoperative side effects, a study shows.

Spanish neonatologists say memory boxes, cooling cradles, and follow-up care can help families navigate perinatal grief after the loss of a baby.

Experts examine methodological limitations, confounding factors, and inconsistent findings while considering how research quality shapes perceptions of potential harm.

In a national inpatient sample, palliative care reached just 10% of hematologic malignancy admissions, often only in the highest-acuity cases.

News All Time

Coma Therapy Tied to Poor Outcomes in Nonconvulsive SE

Patients with nonconvulsive status epilepticus treated with therapeutic coma experience markedly higher rates of complications and mortality than those not receiving the treatment.

Whole Person Approach to Pain Management for Vets in Hospice

This quality improvement project aims to support the uptake and utilization of nonpharmacological pain management interventions for veterans receiving inpatient hospice care.

Axial PsA Diagnosis: Applying AXIS Evidence in Practice

Dr Denis Poddubnyy discusses data from the AXIS study that inform his approach to diagnosing axial psoriatic arthritis.

Doc Sues Malpractice Insurer for Refusing to Settle Lawsuit

A South Carolina ob/gyn says MagMutual should have settled a patient’s malpractice lawsuit after a birth injury.

Cancer Pain Remains a Major Clinical Challenge

From nerve blocks to intrathecal systems, specialists say advanced pain strategies may help when standard analgesics fall short.

Outpatient Palliative Care Consult and End-of-Life Outcomes

This study evaluated the impact of outpatient palliative care consultation on Life-Sustaining Treatment note completion, hospice referral rates, and venue of death.

French Experts Say Medical Hypnosis May Ease ENT Procedures

Clinicians at a French hospital describe hypnosis as a complementary approach that may help patients in different age groups manage anxiety and pain during procedures.

Inpatient Palliative Care in Gynecological Malignancies

This study evaluated the national prevalence, trends, and inpatient outcomes of palliative care use among women hospitalized with gynecological malignancies.

Half of Veterans With Stage IV Cancer Die Without Hospice

Hospice care improves symptom control, reduces ICU utilization, and raises family-rated quality of dying among patients with advanced cancer.

Disposables Dominate Cesarean Anesthesia Carbon Footprint

Disposable items account for the majority of anesthesia-related carbon emissions during cesarean delivery, with a notable portion coming from products that are opened but discarded without use.

Trust Is Earned, Not Assumed

Trust flows both ways between physicians and their patients, says John Whyte, MD, MPH, CEO and executive vice president of the American Medical Association. Dr Whyte shares how he seeks to build that trust.

Hallucinogens: Overhyped and Underwhelming

Enthusiasm for hallucinogens has surged, but has the evidence kept pace? Dr Nassir Ghaemi examines the research behind ketamine, psilocybin, and MDMA — and argues for a more critical look.

Medicine Is a Team Sport

John Whyte, MD, MPH, CEO and executive vice president of the AMA, shares his advice for new physicians on how to build trust with their patients.

Poor Function Before ICU Admission Tied to Later Death Risk

Frailty and functional dependency before admission are associated with an increased risk for mortality after admission to the ICU, although the evidence remains uncertain.

Social Egg Freezing: Choice, Business, or Burden?

Growing interest in egg preservation raises questions about access, affordability, informed consent, and whether workplace pressures shift reproductive responsibility onto women.

Booming Weight-loss Drug Demand in Brazil Fuels Thriving Black Market and Health Fears

When Brazilian customs agents opened jars of dulce de leche aboard a tourist bus arriving from Paraguay in April, they discovered hundreds of vials of tirzepatide, the...

Recommended News For You

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

The top three drugs for multiple myeloma treatment upfront are four.

Un nou sistem de endoscopică imaging are capacitatea de a detecta mai mulți fluorescent tracers.

Immunotherapy after surgery is good for patients with advanced cancer

Highly Successful Treatment of Lynch Syndrome Patients with PD-1 Inhibitors for Colorectal Cancer.

Asymptomatic or Minimally Symptomatic Myelofibrosis

EBCC: European Breast Cancer Conference

Recommended Articles For You

HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia 

Revolutionizing Cancer Care: The Impact of Darzalex Faspro 

Engineered Immune Cells for Brain Tumors: Mechanisms, Clinical Impact, and Future Directions 

RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Emicizumab in Infants With Hemophilia A: Safe and Effective Use.

2.

Abnormal Shadow on Chest Radiograph

3.

Research indicates that combining AI models enhances the ability to predict breast cancer risk.

4.

For some patients with bladder cancer that has invaded the muscle, trimodality therapy is just as effective as radical cystectomy.

5.

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

1.

Oncologic Emergencies Requiring Intensive Care: A Comprehensive Review

2.

Survivorship Care Planning Beyond Active Cancer Treatment: Advancing Care Continuity for Cancer Survivors

3.

The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond

4.

Therapeutic Advances in Tumor Mechanical Microenvironment Targeting

5.

Drug-Induced Coagulation Factor Suppression: Mechanisms, Clinical Features, and Management

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

2.

Evidence-Based Oncology

3.

Teaching Coagulation Pathways Through Interactive Thrombin Generation Models

4.

Advances in Modern Cancer Treatment

5.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot